CZCan Zhang

Can Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Can Zhang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The causal relationship in hypertensive encephalopathy: mechanistic analysis of five specific circulating cytokines

    by Pengfei Zhang, Yijia Huang, Haoying Li, Can Zhang, Zhiren Chen

    Objectives: To investigate the causal relationship between genetically predicted levels of five circulating cytokines – CXCL11, IL-2, IL-4, leukemia inhibitory factor (LIF), and neurotrophin-3 (NT-3) – and the risk of hypertensive encephalopathy using a two-sample Mendelian randomization (MR) approach. Methods: Single nucleotide polymorphisms (SNPs) strongly associated with each cytokine (p < 5 × 10 −8 ) were selected from publicly available GWAS data. Summary statistics for HE were obtained from the FinnGen biobank (endpoint: I9_HYPERTENC). MR analyses were conducted using inverse-variance weighted (IVW), MR-Egger, weighted median, and weighted mode methods. Sensitivity analyses included heterogeneity testing, MR-Egger intercept assessment, and leave-one-out analysis. Results: Genetically higher levels of IL-2 (OR=0.35, 95 % CI: 0.13–0.99, p = 0.043), IL-4 (OR=0.50, 95 % CI: 0.30–0.85, p = 0.010), and NT-3 (OR=0.46, 95 % CI: 0.28–0.75, p = 0.0038) were significantly associated with lower risk of HE. CXCL11 showed a significant positive association with HE risk (OR=2.79, 95 % CI: 1.26–6.20, p = 0.028). LIF displayed a non-significant trend toward protection (OR=0.43, p = 0.060). Results were consistent across sensitivity analyses with no evidence of pleiotropy or heterogeneity. Conclusions: This Mendelian randomization study provides evidence that genetically determined levels of IL-2, IL-4, and NT-3 are protective against hypertensive encephalopathy, while CXCL11 is a risk factor. These cytokines may serve as potential biomarkers or therapeutic targets for HE.